Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 461

1.

Hyperthermic intraperitoneal chemotherapy in management of malignant intraductal papillary mucinous neoplasm with peritoneal dissemination: Case report.

Sirisai C, Yonemura Y, Ishibashi H, Wakama S, Mizumoto A.

Int J Surg Case Rep. 2019;63:85-88. doi: 10.1016/j.ijscr.2019.09.033. Epub 2019 Sep 24.

2.

Pathological assessment of cytoreductive surgery specimens and its unexplored prognostic potential-a prospective multi-centric study.

Bhatt A, Yonemura Y, Benzerdjeb N, Mehta S, Mishra S, Parikh L, Kammar P, Shah MY, Prabhu A, Shaikh S, Patel MD, Isaac S, Glehen O.

Eur J Surg Oncol. 2019 Jul 16. pii: S0748-7983(19)30577-3. doi: 10.1016/j.ejso.2019.07.019. [Epub ahead of print]

PMID:
31337527
3.

Prognostic significance of the presence of epithelial cell clusters in the ascites of patients with pseudomyxoma peritonei.

Ishida M, Mizumoto A, Yonemura Y, Kashu I, Takemura S, Tsuta K.

Diagn Cytopathol. 2019 Oct;47(10):1024-1027. doi: 10.1002/dc.24262. Epub 2019 Jun 19.

PMID:
31218847
4.

Soluble NKG2D Ligands Are Potential Biomarkers and Sentinels of Immune-Mediated Bone Marrow Injury in Bone Marrow Failure Syndromes.

Murata S, Mushino T, Hosoi H, Kuriyama K, Nishikawa A, Nagakura S, Horikawa K, Yonemura Y, Nakakuma H, Sonoki T, Hanaoka N.

Acta Haematol. 2019 Jun 19:1-7. doi: 10.1159/000500657. [Epub ahead of print]

PMID:
31216534
5.

Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.

Hao Y, Liu Y, Ishibashi H, Wakama S, Nishino E, Yonemura Y.

Eur J Surg Oncol. 2019 Aug;45(8):1493-1497. doi: 10.1016/j.ejso.2019.03.011. Epub 2019 Mar 9.

PMID:
30948161
6.

Prognostic Factors of Malignant Peritoneal Mesothelioma Experienced in Japanese Peritoneal Metastasis Center.

Yonemura Y, Canbay E, Wakama S, Sako S, Ishibashi H, Hirano M, Motoi S, Mizumoto A, Takao N, Ichinose M, Noguchi K, Liu Y, Fushida S.

Gan To Kagaku Ryoho. 2019 Feb;46(2):395-399.

PMID:
30914572
7.

Analysis of Treatment Failure after Complete Cytoreductive Surgery for Peritoneal Metastasis from Appendiceal Mucinous Neoplasm at a Japanese High Volume Center for Peritoneal Surface Malignancy.

Yonemura Y, Canbay E, Wakama S, Sako S, Ishibashi H, Hirano M, Motoi S, Mizumoto A, Takao N, Ichinose M, Noguchi K, Liu Y, Fushida S, Li Y.

Gan To Kagaku Ryoho. 2019 Feb;46(2):251-258.

PMID:
30914528
8.

History of Peritoneal Surface Malignancy Treatment in Japan.

Yonemura Y, Sako S, Wakama S, Ishibashi H, Mizumoto A, Takao N, Ichinose M, Noguchi K, Liu Y, Motoi S, Taniguchi K, Fushida S.

Indian J Surg Oncol. 2019 Feb;10(Suppl 1):3-11. doi: 10.1007/s13193-019-00893-x. Epub 2019 Feb 19. Review.

PMID:
30886486
9.

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination.

Yu HH, Yonemura Y, Hsieh MC, Lu CY, Wu SY, Shan YS.

Ther Clin Risk Manag. 2019 Jan 14;15:129-136. doi: 10.2147/TCRM.S190641. eCollection 2019.

10.

Reduction in adverse transfusion reactions with increased use of washed platelet concentrates in Japan-A retrospective multicenter study.

Ikebe E, Matsuoka S, Tanaka A, Yonemura Y, Fujii Y, Ohsaka A, Okazaki H, Kitazawa J, Ohtani S, Nakayama T, Momose SY, Miwa I, Taira R, Toyota K, Kino S, Kato H, Hamaguchi I.

Transfus Apher Sci. 2019 Apr;58(2):162-168. doi: 10.1016/j.transci.2018.12.021. Epub 2019 Jan 6.

PMID:
30670326
11.

Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.

Alzahrani NA, Valle SJ, Fisher OM, Sugarbaker PH, Yonemura Y, Glehen O, Goere D, Honore C, Brigand C, de Hingh I, Verwaal VJ, Deraco M, Baratti D, Kusamura S, Pocard M, Piso P, Maerz L, Marchal F, Moran B, Levine EA, Dumont F, Pezet D, Abboud K, Kozman MA, Liauw W, Morris DL; Peritoneal Surface Oncology Group International (PSOGI) and Big-RENAPE groups.

J Surg Oncol. 2019 Mar;119(3):336-346. doi: 10.1002/jso.25277. Epub 2018 Dec 16.

PMID:
30554404
12.

Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer.

Huang C, Liu J, Xiong B, Yonemura Y, Yang X.

Gene. 2019 Feb 15;685:202-210. doi: 10.1016/j.gene.2018.11.022. Epub 2018 Nov 9.

PMID:
30415009
13.

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.

Amblard I, Mercier F, Bartlett DL, Ahrendt SA, Lee KW, Zeh HJ, Levine EA, Baratti D, Deraco M, Piso P, Morris DL, Rau B, Tentes AAK, Tuech JJ, Quenet F, Akaishi E, Pocard M, Yonemura Y, Lorimier G, Delroeux D, Villeneuve L, Glehen O, Passot G; PSOGI and BIG RENAPE working groups.

Eur J Surg Oncol. 2018 Sep;44(9):1378-1383. doi: 10.1016/j.ejso.2018.04.023. Epub 2018 Jun 19.

PMID:
30131104
14.

The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).

Bushati M, Rovers KP, Sommariva A, Sugarbaker PH, Morris DL, Yonemura Y, Quadros CA, Somashekhar SP, Ceelen W, Dubé P, Li Y, Verwaal VJ, Glehen O, Piso P, Spiliotis J, Teo MCC, González-Moreno S, Cashin PH, Lehmann K, Deraco M, Moran B, de Hingh IHJT.

Eur J Surg Oncol. 2018 Dec;44(12):1942-1948. doi: 10.1016/j.ejso.2018.07.003. Epub 2018 Jul 20.

PMID:
30075978
15.

Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failure.

Hosokawa K, Sugimori C, Ishiyama K, Takamatsu H, Noji H, Shichishima T, Obara N, Chiba S, Ninomiya H, Shirasugi Y, Nakamura Y, Ando K, Ueda Y, Yonemura Y, Kawaguchi T, Nishimura JI, Kanakura Y, Nakao S.

Ann Hematol. 2018 Dec;97(12):2289-2297. doi: 10.1007/s00277-018-3443-1. Epub 2018 Jul 24.

PMID:
30039297
16.

Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan.

Ueda Y, Obara N, Yonemura Y, Noji H, Masuko M, Seki Y, Wada K, Matsuda T, Akiyama H, Ikezoe T, Chiba S, Kanda Y, Kawaguchi T, Shichishima T, Nakakuma H, Okamoto S, Nishimura JI, Kanakura Y, Ninomiya H.

Int J Hematol. 2018 Aug;108(2):233-235. doi: 10.1007/s12185-018-2486-3.

PMID:
29980910
17.

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience.

Liu Y, Yonemura Y, Levine EA, Glehen O, Goere D, Elias D, Morris DL, Sugarbaker PH, Tuech JJ, Cashin P, Spiliotis JD, de Hingh I, Ceelen W, Baumgartner JM, Piso P, Katayama K, Deraco M, Kusamura S, Pocard M, Quenet F, Fushita S; BIG-RENAPE Group.

Ann Surg Oncol. 2018 May;25(5):1184-1192. doi: 10.1245/s10434-018-6369-x. Epub 2018 Feb 26.

18.

Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials.

Coccolini F, Nardi M, Montori G, Ceresoli M, Celotti A, Cascinu S, Fugazzola P, Tomasoni M, Glehen O, Catena F, Yonemura Y, Ansaloni L.

Int J Surg. 2018 Mar;51:120-127. doi: 10.1016/j.ijsu.2018.01.008. Epub 2018 Feb 20. Review.

PMID:
29413875
19.

Comprehensive Treatment Using Cytoreductive Surgery Combined with Perioperative Chemotherapy Improved Outcome of Colorectal Cancer Patients with Metachronous Peritoneal Metastasis.

Yonemura Y, Canbay E, Sako S, Wakama S, Ishibashi H, Hirano M, Mizumoto A, Takao N, Ichinose M, Noguchi K, Motoi S, Liu Y, Li Y, Taniguchi K.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1939-1942.

PMID:
29394827
20.

[A Case of Colorectal Cancer with Peritoneal Dissemination and Liver Metastasis That Responded to Comprehensive Treatment by Chemotherapy and CRS plus HIPEC].

Fujimoto T, Suzuki N, Tomochika S, Tanaka H, Matsui H, Sakamoto K, Takeda S, Yamamoto S, Yoshino S, Hazama S, Ishibashi H, Yonemura Y, Ueno T, Nagano H.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1704-1707. Japanese.

PMID:
29394749
21.

Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan.

Ueda Y, Obara N, Yonemura Y, Noji H, Masuko M, Seki Y, Wada K, Matsuda T, Akiyama H, Ikezoe T, Chiba S, Kanda Y, Kawaguchi T, Shichishima T, Nakakuma H, Okamoto S, Nishimura JI, Kanakura Y, Ninomiya H.

Int J Hematol. 2018 Jun;107(6):656-665. doi: 10.1007/s12185-018-2409-3. Epub 2018 Jan 30. Erratum in: Int J Hematol. 2018 Aug;108(2):233-235.

PMID:
29383624
22.

Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients.

Mercier F, Passot G, Villeneuve L, Levine EA, Yonemura Y, Goéré D, Sugarbaker PH, Marolho C, Bartlett DL, Glehen O; BIG-RENAPE Working Group.

Ann Surg Oncol. 2018 Apr;25(4):1094-1100. doi: 10.1245/s10434-017-6299-z. Epub 2017 Dec 13.

PMID:
29238881
24.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center.

Yu HH, Yonemura Y, Hsieh MC, Mizumoto A, Wakama S, Lu CY.

Cancer Manag Res. 2017 Oct 19;9:513-523. doi: 10.2147/CMAR.S147227. eCollection 2017.

25.

Development of a novel Schiff base derivative for enhancing the anticancer potential of 5-aminolevulinic acid-based photodynamic therapy.

Shinohara Y, Endo Y, Abe C, Shiba I, Ishizuka M, Tanaka T, Yonemura Y, Ogura SI, Tominaga M, Yamada H, Uto Y.

Photodiagnosis Photodyn Ther. 2017 Dec;20:182-188. doi: 10.1016/j.pdpdt.2017.10.014. Epub 2017 Oct 19.

PMID:
29056554
26.

Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Sardi A, Sipok A, Baratti D, Deraco M, Sugarbaker P, Salti G, Yonemura Y, Sammartino P, Glehen O, Bakrin N, Díaz-Montes TP, Gushchin V.

Eur J Surg Oncol. 2017 Nov;43(11):2170-2177. doi: 10.1016/j.ejso.2017.08.011. Epub 2017 Sep 7.

PMID:
28967566
27.

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence.

Huang CQ, Min Y, Wang SY, Yang XJ, Liu Y, Xiong B, Yonemura Y, Li Y.

Oncotarget. 2017 Apr 27;8(33):55657-55683. doi: 10.18632/oncotarget.17497. eCollection 2017 Aug 15. Review.

28.

A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study).

Kobayashi T, Nannya Y, Ichikawa M, Oritani K, Kanakura Y, Tomita A, Kiyoi H, Kobune M, Kato J, Kawabata H, Shindo M, Torimoto Y, Yonemura Y, Hanaoka N, Nakakuma H, Hasegawa D, Manabe A, Fujishima N, Fujii N, Tanimoto M, Morita Y, Matsuda A, Fujieda A, Katayama N, Ohashi H, Nagai H, Terada Y, Hino M, Sato K, Obara N, Chiba S, Usuki K, Ohta M, Imataki O, Uemura M, Takaku T, Komatsu N, Kitanaka A, Shimoda K, Watanabe K, Tohyama K, Takaori-Kondo A, Harigae H, Arai S, Miyazaki Y, Ozawa K, Kurokawa M; for National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Am J Hematol. 2017 Dec;92(12):1324-1332. doi: 10.1002/ajh.24905. Epub 2017 Sep 28.

29.

A novel phenylphthalimide derivative, pegylated TC11, improves pharmacokinetic properties and induces apoptosis of high-risk myeloma cells via G2/M cell-cycle arrest.

Aida S, Hozumi M, Ichikawa D, Iida K, Yonemura Y, Tabata N, Yamada T, Matsushita M, Sugai T, Yanagawa H, Hattori Y.

Biochem Biophys Res Commun. 2017 Nov 4;493(1):514-520. doi: 10.1016/j.bbrc.2017.08.159. Epub 2017 Sep 1.

PMID:
28867196
30.

A case of ovarian growing teratoma syndrome treated by cytoreductive surgery.

Goto Y, Mizumoto A, Hirano M, Takao N, Ichinose M, Noguchi K, Kasyu I, Ishida M, Yonemura Y.

Int Cancer Conf J. 2017 Aug 3;6(4):188-192. doi: 10.1007/s13691-017-0304-z. eCollection 2017 Oct.

31.

Registries on peritoneal surface malignancies throughout the world, their use and their options.

Verwaal VJ, Rau B, Jamali F, Gilly FN, de Hingh I, Takala H, Syk I, Pelz J, Mulsow J, van der Speeten K, Shigeki K, Iversen LH, Mohamed F, Glehen O, Younan R, Yarema R, Gonzalez-Moreno S, O'Dwyer S, Yonemura Y, Sugarbaker P.

Int J Hyperthermia. 2017 Aug;33(5):528-533. doi: 10.1080/02656736.2017.1315178.

PMID:
28540833
32.

Photodynamic Detection of Peritoneal Metastases Using 5-Aminolevulinic Acid (ALA).

Yonemura Y, Endo Y, Canbay E, Liu Y, Ishibashi H, Mizumoto A, Hirano M, Imazato Y, Takao N, Ichinose M, Noguchi K, Li Y, Wakama S, Yamada K, Hatano K, Shintani H, Yoshitake H, Ogura SI.

Cancers (Basel). 2017 Mar 1;9(3). pii: E23. doi: 10.3390/cancers9030023. Review.

33.

Treatment Failure Following Complete Cytoreductive Surgery for Peritoneal Metastasis from Colorectal Cancer.

Yonemura Y, Canbay E, Shintani H, Yoshitake H, Hatano K, Sako S, Ishibashi H, Hirano M, Mizumoto A, Takao N, Ichinose M, Noguchi K, Liu Y, Wakama S, Fushida S, Li Y.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1435-1439.

PMID:
28133015
34.

Current status and future prospects of clinical trials on CRS + HIPEC for gastric cancer peritoneal metastases.

Ji ZH, Peng KW, Yu Y, Li XB, Yonemura Y, Liu Y, Sugarbaker PH, Li Y.

Int J Hyperthermia. 2017 Aug;33(5):562-570. doi: 10.1080/02656736.2017.1283065. Review.

PMID:
28124576
35.

Treatment of peritoneal metastases from small bowel adenocarcinoma.

Rovers KP, de Bree E, Yonemura Y, de Hingh IH.

Int J Hyperthermia. 2017 Aug;33(5):571-578. doi: 10.1080/02656736.2016.1266700. Review.

PMID:
27919181
36.

Specific combinations of presenilins and Aph1s affect the substrate specificity and activity of γ-secretase.

Yonemura Y, Futai E, Yagishita S, Kaether C, Ishiura S.

Biochem Biophys Res Commun. 2016 Sep 30;478(4):1751-7. doi: 10.1016/j.bbrc.2016.09.018. Epub 2016 Sep 5.

37.

Inhibition of cargo export at ER exit sites and the trans-Golgi network by the secretion inhibitor FLI-06.

Yonemura Y, Li X, Müller K, Krämer A, Atigbire P, Mentrup T, Feuerhake T, Kroll T, Shomron O, Nohl R, Arndt HD, Hoischen C, Hemmerich P, Hirschberg K, Kaether C.

J Cell Sci. 2016 Oct 15;129(20):3868-3877. Epub 2016 Sep 1.

38.

Evolution of management in peritoneal surface malignancies.

Canbay E, Torun BC, Torun ES, Yonemura Y.

Ulus Cerrahi Derg. 2015 Sep 1;32(3):203-7. doi: 10.5152/UCD.2016.3375. eCollection 2016. Review.

39.

Effects of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Neoadjuvant Intraperitoneal/Systemic Chemotherapy on Peritoneal Metastases from Gastric Cancer.

Yonemura Y, Ishibashi H, Hirano M, Mizumoto A, Takeshita K, Noguchi K, Takao N, Ichinose M, Liu Y, Li Y.

Ann Surg Oncol. 2017 Feb;24(2):478-485. doi: 10.1245/s10434-016-5487-6. Epub 2016 Aug 9.

PMID:
27506661
40.

Early Tumor Shrinkage and Depth of Response as Predictors of Favorable Treatment Outcomes in Patients with Metastatic Colorectal Cancer Treated with FOLFOX Plus Cetuximab (JACCRO CC-05).

Tsuji A, Sunakawa Y, Ichikawa W, Nakamura M, Kochi M, Denda T, Yamaguchi T, Shimada K, Takagane A, Tani S, Kotaka M, Kuramochi H, Furushima K, Koike J, Yonemura Y, Takeuchi M, Fujii M, Nakajima T.

Target Oncol. 2016 Dec;11(6):799-806.

PMID:
27306648
41.

Should total gastrectomy and total colectomy be considered for selected patients with severe tumor burden of pseudomyxoma peritonei in cytoreductive surgery?

Liu Y, Mizumoto A, Ishibashi H, Takeshita K, Hirano M, Ichinose M, Takegawa S, Yonemura Y.

Eur J Surg Oncol. 2016 Jul;42(7):1018-23. doi: 10.1016/j.ejso.2016.04.059. Epub 2016 May 19.

PMID:
27241925
42.

5-Aminolevulinic Acid Fluorescence in Detection of Peritoneal Metastases.

Yonemura Y, Canbay E, Ishibashi H, Nishino E, Endou Y, Sako S, Ogura S.

Asian Pac J Cancer Prev. 2016;17(4):2271-5.

43.

A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.

Yonemura Y, Canbay E, Li Y, Coccolini F, Glehen O, Sugarbaker PH, Morris D, Moran B, Gonzaletz-Moreno S, Deraco M, Piso P, Elias D, Batlett D, Ishibashi H, Mizumoto A, Verwaal V, Mahtem H.

Eur J Surg Oncol. 2016 Aug;42(8):1123-31. doi: 10.1016/j.ejso.2016.03.016. Epub 2016 Apr 9. Review.

PMID:
27160355
44.

Recommendations for the electronic pre-transfusion check at the bedside.

Ohsaka A, Kato H, Kino S, Kawabata K, Kitazawa J, Sugimoto T, Takeshita A, Baba K, Hamaguchi M, Fujii Y, Horiuchi K, Yonemura Y, Hamaguchi I, Handa M; Japan Society of Transfusion Medicine and Cell Therapy Working Party on Safety Management of Blood Transfusions.

Blood Transfus. 2016 Sep;14(5):419-24. doi: 10.2450/2016.0184-15. Epub 2016 Mar 21. No abstract available.

45.

Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis.

Coccolini F, Catena F, Glehen O, Yonemura Y, Sugarbaker PH, Piso P, Ceresoli M, Montori G, Ansaloni L.

Eur J Surg Oncol. 2016 Sep;42(9):1261-7. doi: 10.1016/j.ejso.2016.03.035. Epub 2016 Apr 19. Review.

PMID:
27134147
46.

Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy to Treat Advanced/Recurrent Epithelial Ovarian Cancer: Results from a Retrospective Study on Prospectively Established Database.

Sun JH, Ji ZH, Yu Y, Wu HT, Huang CQ, Zhang Q, Yang XJ, Yonemura Y, Li Y.

Transl Oncol. 2016 Apr;9(2):130-138. doi: 10.1016/j.tranon.2016.02.002.

47.

Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study.

Sun JH, Ji ZH, Peng KW, Wu HT, Zhang Q, Yonemura Y, Li Y.

Int J Hyperthermia. 2016 May;32(3):289-97. doi: 10.3109/02656736.2016.1146802. Epub 2016 Mar 16.

PMID:
26982735
48.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Dissemination from Small Bowel Malignancy: Results from a Single Specialized Center.

Liu Y, Ishibashi H, Takeshita K, Mizumoto A, Hirano M, Sako S, Takegawa S, Takao N, Ichinose M, Yonemura Y.

Ann Surg Oncol. 2016 May;23(5):1625-31. doi: 10.1245/s10434-015-5056-4. Epub 2015 Dec 30.

PMID:
26717938
49.

[Postoperative Analgesia in Peritonectomy for Patients with Peritoneal Surface Malignancy].

Tomita A, Satani M, Morimoto A, Ishibashi H, Yonemura Y.

Masui. 2015 Feb;64(2):208-11. Japanese.

PMID:
26121820
50.

Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis.

Coccolini F, Catena F, Glehen O, Yonemura Y, Sugarbaker PH, Piso P, Montori G, Ansaloni L.

Eur J Surg Oncol. 2015 Jul;41(7):911-9. doi: 10.1016/j.ejso.2015.03.231. Epub 2015 Apr 14. Review.

PMID:
25936764

Supplemental Content

Loading ...
Support Center